PARP1
- [1]. Wang F, et al. PARPs and PARP inhibitors: molecular mechanisms and clinical applications. Mol Biomed. 2025 Dec 29;6(1):152. [Content Brief]
- [2]. Sciencedirect.topics.
- [3]. Yelamos J, et al. PARP-1 and PARP-2: New players in tumour development. Am J Cancer Res. 2011;1(3):328-346. Epub 2011 Jan 8. PMID: 21968702; PMCID: PMC3180065. [Content Brief]
- [4]. Petropoulos M, et al. Transcription-replication conflicts underlie sensitivity to PARP inhibitors. Nature. 2024 Apr;628(8007):433-441. [Content Brief]
- [5]. Rose M, et al. PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance. Front Cell Dev Biol. 2020 Sep 9;8:564601. [Content Brief]
- [6]. Szántó M, et al. Specific and shared biological functions of PARP2 - is PARP2 really a lil' brother of PARP1? Expert Rev Mol Med. 2024;26:e13.
- [7]. Underhill C, et al. A review of PARP inhibitors: from bench to bedside. Ann Oncol. 2011 Feb;22(2):268-79. [Content Brief]
-
Productos relacionados con PARP1 (204)
Productos relacionados con (204)
-
Antibodies (2)
-
Niraparib tosylate
0 ImagesSynonyms: MK-4827 tosylate -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
AG14361
0 ImagesAG14361 is a potent PARP-1 inhibitor, with a Ki of < 5 nM, and in permeabilized SW620 and intact SW620 cells, the IC50s are 29 nM and 14 nM, respectively. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- Stenoparib
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- OUL232
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- UPF 1069
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
Rucaparib monocamsylate
0 ImagesSynonyms: AG014699 monocamsylate; PF-01367338 monocamsylateRucaparib (AG014699) monocamsylate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib monocamsylate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib monocamsylate has the potential for castration-resistant prostate cancer (CRPC) research. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- RBN-3143
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
PJ34 hydrochloride
0 ImagesPJ34 hydrochloride is an inhibitor of PARP1/2 with IC50 of 110 nM and 86 nM, respectively. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
Venadaparib
0 ImagesSynonyms: IDX-1197 -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
DPQ
0 ImagesDPQ is a selective PARP-1 inhibitor that blocks PARP-1-mediated DNA damage repair and NAD+/ATP consumption, thereby inhibiting excessive inflammatory responses. DPQ inhibits NF-κB pathway activation, reduces the expression of pro-inflammatory factors (such as TNF-α, IL-6) and oxidative stress. DPQ can be used in inflammation-related studies of acute lung injury, myocardial infarction, and neurodegenerative diseases. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
Gomisin N
0 ImagesGomisin N is an orally active lignan compound. Gomisin N can be isolated from Schisandra chinensis. Gomisin N induces Apoptosis in a variety of cells. Gomisin N activates AMPK, Akt, MAPK/ERK, Nrf2, caspase-3 and PARP-1. Gomisin N inhibits GSK3β, nitric oxide (NO), and proinflammatory cytokines (IL-1β, IL-6, TNF-α). Gomisin N has anti-inflammatory, antioxidant, anti-obesity, anti-diabetic, and anti-melanogenesis activities. Gomisin N has anti-tumor activity against cervical cancer and liver cancer. Gomisin N improves Alzheimer's disease. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- AZD-2461
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
iRucaparib-AP6
0 ImagesiRucaparib-AP6 is a highly efficient and specific PROTAC PARP1 degrader. iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
MSC2504877
0 ImagesSynonyms: M2912 -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
Prostaglandin A2
0 ImagesSynonyms: PGA2; MedullinProstaglandin A2 (PGA2) is a Cyclopentenone prostaglandin. Prostaglandin A2 induces Caspase-dependent Apoptosis, activates p53. Prostaglandin A2 activates ERK2 and JNK1/SAPK. Prostaglandin A2 shows antiviral activity against HSV-1. Prostaglandin A2 has anti-tumor effects. Prostaglandin A2 can be used for the research of colorectal cancer, colorectal carcinoma, breast carcinoma, and herpetic keratitis. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
N-Descyclopropanecarbaldehyde Olaparib
0 ImagesN-Descyclopropanecarbaldehyde Olaparib is an analogue of Olaparib (HY-10162) containing DOTA moiety. N-Descyclopropanecarbaldehyde Olaparib is a PARP inhibitor used for synthesizing novel dual EGFR and PARP PROTAC, DP-C-4 (HY-141481). N-Descyclopropanecarbaldehyde Olaparib can be radiolabeled with F-18 or fluorophore for positron emission tomography (PET) or optical imaging in several types of tumor. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- ME0328
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
Veliparib dihydrochloride
0 ImagesSynonyms: ABT-888 dihydrochloride -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- AZ6102
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
Sulfabenzamide
0 ImagesSulfabenzamide (N-Sulfanilylbenzamide) is a sulfonamide antibacterial agent. Sulfabenzamide exhibit antibacterial activity against Staphylococcus aureus (ATCC 25923) and Escherichia coli (ATCC 8739). Sulfabenzamide can promote autophagic cell autophagy in breast cancer cells through p53/ DRAM pathway. Sulfabenzamide increases caspase-3 activity, deactivates PARP1 and DNA-PK, downregulates AKT1 and AKT2. Sulfabenzamide can be used for the researches of breast cancer and bacterial infections. -
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
-
0 ImagesReferencia número:Synonyms:-
Host:
-
Aplicación:
Human,
-
Isotype:
-
Reactivity:
,
-
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -